Precursor Disease
Showing 1 - 25 of >10,000
Parkinson's Disease Trial in Shanghai (hiPSC-DAP)
Not yet recruiting
- Parkinson's Disease
- hiPSC-DAP
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Nov 22, 2023
Parkinson's Disease Trial in Beijing (Autologous induced neural stem cell-derived DA precursor cells)
Recruiting
- Parkinson's Disease
- Autologous induced neural stem cell-derived DA precursor cells
-
Beijing, Beijing, ChinaXuanwu Hospital Capital Medical University
Jun 13, 2023
Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,
Recruiting
- Sickle Cell Disease
- haploidentical stem cell transplant
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 18, 2022
Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
- Sickle Cell Disease
- +3 more
- Alemtuzumab
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,
Not yet recruiting
- Cancer Prevention
- +5 more
- Prolonged Fasting Intervention
- EDUCATION CONTROL
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 28, 2022
COrSIcA: Disease Measurement
Not yet recruiting
- Anal Intraepithelial Neoplasia
- +2 more
- Physical examination
- (no location specified)
May 4, 2023
Pediatric ALL, B Cell, Minimal Residual Disease Trial in Seoul (Blinatumomab for Injection)
Recruiting
- Pediatric ALL, B Cell
- Minimal Residual Disease
- Blinatumomab for Injection
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 20, 2022
Next-generation Sequencing in Pediatric B-ALL Children Patients
Not yet recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- (no location specified)
Apr 19, 2023
Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Low-field magnetic resonance imaging
- +3 more
-
Erlangen, Bavaria, GermanyDepartment of Pediatrics and Adolescent Medicine
Oct 23, 2023
B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)
Recruiting
- B-Cell Lymphoblastic Leukemia
- Acute Lymphoblastic Leukemia
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2023
MRD Detection by NGS in Pediatric B-ALL
Completed
- Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
- MRD
-
Hangzhou, Zhejiang, ChinaThe Children's Hospital of Zhejiang University School of Medicin
Jul 25, 2023
ALL, Recurrent, Adult Trial in Germany (Blinatumomab)
Active, not recruiting
- ALL, Recurrent, Adult
-
Frankfurt (Main), Hessen, Germany
- +21 more
Mar 16, 2022
Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)
Not yet recruiting
- Graft Vs Host Disease
- +5 more
- CliniMACS® device
- (no location specified)
Jul 20, 2023
T-cell Acute Lymphoblastic Leukemia Trial in Chicago (Daratumumab / Hyaluronidase Injection)
Recruiting
- T-cell Acute Lymphoblastic Leukemia
- Daratumumab / Hyaluronidase Injection
-
Chicago, IllinoisNorthwestern
Jun 17, 2022
Acute Lymphoblastic Leukemia Trial in Bergamo, Monza (PTG-CARCIK-CD19)
Recruiting
- Acute Lymphoblastic Leukemia
- PTG-CARCIK-CD19
-
Bergamo, Italy
- +1 more
Feb 12, 2022
Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)
Completed
- Multiple Myeloma
- +11 more
- Pre-biotic foods/drinks
-
Charlottesville, VirginiaUniversity of Virginia
Jan 2, 2023
Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)
Recruiting
- Acute Lymphoid Leukemia
- +3 more
- Prednisone
- +9 more
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
Jul 24, 2023
Cerebral Small Vessel Diseases Trial in Bordeaux (Vascular and ophthalmological examinations)
Recruiting
- Cerebral Small Vessel Diseases
- Vascular and ophthalmological examinations
-
Bordeaux, FranceCHU de Bordeaux
Mar 30, 2022
Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral
Recruiting
- Congenital Hemolytic Anemia
- Sickle Cell Disease
- Peripheral blood hematopoietic progenitor cell (PBPC) transplant
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Acute Lymphocytic Leukemia Trial (Inotuzumab ozogamicin)
Not yet recruiting
- Acute Lymphocytic Leukemia
- Inotuzumab ozogamicin
- (no location specified)
Jul 11, 2022
Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)
Active, not recruiting
- Sickle Cell Anemia
- PBSC Transplant
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022
Recurrent Acute Myeloid Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia Trial
Not yet recruiting
- Recurrent Acute Myeloid Leukemia
- +7 more
- Anti-CD123 ADC IMGN632
- +7 more
- (no location specified)
Dec 28, 2022
Fitness and Lung Function Among Survivors of Heart Transplant,
Not yet recruiting
- Chronic Lung Disease
- +3 more
- Physical activity
- (no location specified)
Mar 25, 2022
T-lymphoblastic Lymphoma, Relapsed Disease, Refractory Lymphoma Trial in Shanghai (BCL2 Inhibitor plus IM2 regimen)
Recruiting
- T-lymphoblastic Lymphoma
- +5 more
- BCL2 Inhibitor plus IM2 regimen
-
Shanghai, Shanghai, ChinaShanghai General hospital,Shanghai Jiao Tong University School o
Jan 10, 2023
Recurrent B Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Refractory B Acute Lymphoblastic Leukemia
Recruiting
- Recurrent B Acute Lymphoblastic Leukemia
- +3 more
- Blinatumomab
- +2 more
-
New Haven, Connecticut
- +6 more
Jul 9, 2022